Au
Not verified

Aurion Biotech

What we write about

EventiHealthMedicine - variousOpticsPharmaceuticals
18/10/2025
Eventi
Health
Medicine - various
Scienza
Pharmaceuticals
Optics
Biotechnology
Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months
1.00

Contact details

Social Media

Followers
0
Compatibility
0